○Benni Iskandar1,2, Hsiu-Mei Lin3, Ching-Kuo Lee2 (1. Department of Pharmaceutical Technology, Sekolah Tinggi Ilmu Farmasi Riau (STIFAR), Pekanbaru, Riau, Indonesia, 28292, 2. School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan, 11031, 3. National Taiwan Ocean University, Department of Bioscience and Biotechnology, Keelung 202, Taiwan)
Session information
Interdisciplinary Session
[28ISP] Interdisciplinary Session Poster: Nucleic acids/DDS/Vaccines
Tue. Mar 28, 2023 9:00 AM - 3:50 PM [Room P3] Frontier Research in Applied Sciences Building: Foyer (2F)
Discussion time: 15:10-15:50
○So Hyeon Lim1, Jung Min Yun1, Ae Ri Kim1 (1. College of Pharmacy, CHA University, Seongnam, 463-400, Republic of Korea)
○Ayaka Ichikawa1, Takashi Osawa2, Satoshi Obika2,3,4 (1. Sch. Pharm. Sci., Osaka Univ., 2. Grad. Sch. Pharm. Sci., Osaka Univ., 3. NIBIOHN, 4. OTRI)
○Atsushi Mikami1, Shohei Mori1, Takashi Osawa1, Satoshi Obika1,2,3 (1. Grad. Sch. Pharm. Sci., Osaka Univ., 2. NIBIOHN, 3. OTRI)
○Riku Kumagai1, Takaya Sugiura2, Hibiki Komine2, Takao Yamaguchi2, Satoshi Obika2,3,4 (1. Sch. Pharm. Sci., Osaka Univ., 2. Grad. Sch. Pharm. Sci., Osaka Univ., 3. NIBIOHN, 4. OTRI)
○Sayoko Ito1, Natsumi Yano2, Takashi Osawa2, Satoshi Obika2,3,4 (1. Sch. Pharm. Sci., Osaka Univ., 2. Grad. Sch. Pharm. Sci., Osaka Univ., 3. NIBIOHN, 4. OTRI)
[28ISP-07 (26B2-am13S)] Enzymatic synthesis of modified oligonucleotides with extended random region
○Kaito Nitatouge1,2, Kenta Ishida2,3, Hidekazu Hoshino2, Yuuya Kasahara2,3, Satoshi Obika2,3,4 (1. Sch. Pharm. Sci., Osaka Univ., 2. NIBIOHN, 3. Grad. Sch. Pharm. Sci., Osaka Univ. , 4. OTRI, Osaka Univ.)
○Hidekazu Hoshino1, Yuuya Kasahara1,2, Satoshi Obika1,2,3 (1. NIBIOHN, 2. Grad. Sch. Pharm. Sci., Osaka Univ., 3. OTRI, Osaka Univ.)
○Kenta Ishida1,2, Youko Senga2, Kaito Nitatouge3, Masahiro Oka2, Nobumichi Ohoka4, Hidekazu Hoshino2, Yosuke Demizu4, Takao Inoue4, Satoshi Obika1,2,5, Yuuya Kasahara1,2 (1. Grad. Sch. Pharm. Sci., Osaka Univ., 2. NIBIOHN, 3. Sch. Pharm. Sci., Osaka Univ., 4. NIHS, 5. OTRI, Osaka Univ.)
○Yusuke Kawamoto1, You Wu1, Soyoung Park2, Hiroshi Sugiyama3,4, Yuki Takahashi1, Yoshinobu Takakura1 (1. Grad. Sch. Pharm., Kyoto Univ., 2. IFReC, Osaka Univ., 3. Grad. Sch. Sci., Kyoto Univ., 4. iCeMS, Kyoto Univ.)
○TAHIA TAUFIQ1,2, Taslima Rahman Chowdhury1,2, Md Ariful Islam1, Yuuya Kasahara1,2, Taisuke Nakayama2, Haruhiko Kamada2, Takashi Osawa1, Satoshi Obika1,2,3 (1. Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan, 2. National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki, Osaka 567-0085, Japan, 3. Institute for Open and Transdisciplinary Research Initiatives (OTRI), Osaka University, 1-3 Yamadaoka, Suita, Osaka 565-0871, Japan)
○Masayuki Fujii1, Yojiro Kotake1, Yasuo Shiohama2 (1. Sci Tech., Kindai University, 2. Sch. Med., University of Yamaguchi)
○Takanori Kubo1, Rina Tansou1, Yoshio Nishimura2, Keishiro Mihara3, Kazuyoshi Yanagihara4, Toshio Seyama1 (1. Fac. Pharm., Yasuda Women’s Univ, 2. Sch. Pharm. Sci., Ohu Univ., 3. Fujita Health Univ., 4. Nat. Can. Cen.)
○Chihiro Oda1,2, Yuuya Kasahara2,3, Harumi Yamaguma2, Masahito Shimojo3, Satoshi Obika2,3,4 (1. Sch. Pharm. Sci., Osaka Univ., 2. NIBIOHN, 3. Grad. Sch. Pharm. Sci., Osaka Univ., 4. OTRI, Osaka Univ.)
○Yuuya Kasahara1,2, Natsumi Kameoka1, Harumi Yamaguma1, Satoshi Obika1,2,3 (1. NIBIOHN, 2. Grad. Sch. Pharm. Sci., Osaka Univ., 3. OTRI, Osaka Univ.)
○Yuta Yoshizaki1, Tomohiro Konno1 (1. Grad. Sch. of Pharm. Sci., Tohoku Univ.)
○Sachiko Toma-Fukai1,2, Hiroaki Matsuura3, Naoki Sakai3, Kunio Hirata3, Yuki Matsuya2, Hikaru Shimizu2, Koki Hayama1, Shoma Imamura1, Ruri Kojima4, Toshiyuki Shimizu2, Hironari Kamikubo1, Daisuke Kawauchi5, Shinya Ohata2,4 (1. Grad. Sch. Sci. and Tech., NAIST, 2. Grad. Sch. Pharm. Sci., The Univ. of Tokyo, 3. RSC, 4. Musashino Univ., 5. NCNP)
○Masaru Kato1, Yuka Kanai1, Yuuki Manda1, Eiichi Yamamoto2, Shota Miyazaki3, Chiaki Aoyama3, Masatoshi Akitake3, Shigenori Ohta3 (1. Sch. Pharm., Showa Univ., 2. National Institute of Health Sciences, 3. GL Sciences Inc.)
○Yu Mizukami1, Ryo Kawakami1, Rumina Shima1, Shiori Shibukawa1, Ryosuke Fukuda1, Tatsuya Murakami1,2 (1. Grad. Sch. Eng., Toyama Pref. Univ., 2. iCeMS, Kyoto Univ.)
○Yusuke Tamenori1, Satoshi Obika2,3,4, Masahito Shimojo2 (1. Sch. Pharm. Sci., Osaka Univ., 2. Grad. Sch. Pharm. Sci., 3. OTRI, Osaka Univ., 4. NIBIOHN)
○Ryota Suginaka1, Satoshi Obika1,2,3, Masahito Shimojo1 (1. Grad. Sch. Pharm. Sci., Osaka Univ, 2. NIBIOHN, 3. OTRI)
○Hiroto Kohashi1, Ryu Nagata1, Satoshi Obika1,2,3, Masahito Shimojo1 (1. Grad. Sch. Pharm. Sci., Osaka Univ., 2. OTRI, Osaka Univ., 3. NIBIOHN)
Masaki Kikuchi1, Satoshi Morita1, Masatoshi Wakamori1, Shin Sato1, Tomomi Uchikubo-Kamo1, Mikako Shirouzu1, ○Takashi Umehara1 (1. RIKEN)
○Saeka Nishihara1, Nao Nakamura1, Kiyoshi Kawasaki1 (1. DWCLA)
○Takahiro Kikuchi1, Satoshi Itou1, Shun Kumagaya2, Kosuke Chiba2, Masaki Yamagami2, Kenta Hashizume1 (1. Drug Development Solutions Center, Sekisui Medical Co., Ltd., 2. Research and Development Division, Luxna Biotech Co., Ltd.)
○Mikinaga Mori1, Shiro Sonoke1, Kohei Ono1 (1. FUJIFILM Corporation)
○Kenta Tanito1, Yuta Yokoyama1, Haruka Oishi2, Mayuka Shibata2, Shoichi Hijii2, Ryosuke Kaneko2, Chuya Tateishi1, Shoko Ito2, Akihiro Kishimura1,2,3, Takeshi Mori1,2, Teruki Nii1,2, Yoshiki Katayama1,2,3 (1. Grad. Sch. Syst. Life Sci., Kyushu Univ., 2. Grad. Sch. Engineering, Kyushu University, 3. Int. Res. Center for Mol. Syst., Kyushu Univ.)
○Yuto Honda1,2,3, Shuhei Nagao1,2, Nozomi Matsudaira1,2, Hiroaki Kinoh3, Takahiro Nomoto1,2, Yutaka Miura1,2, Nobuhiro Nishiyama1,2,3 (1. Lab. for Chem. and Life Sci., Tokyo Tech., 2. Dept. of Life Sci. and Tech., Tokyo Tech., 3. Innovation Center of NanoMedicine)
Kasumi Sasaki1, Koji Okuwaki1, Takayuki Furuishi1, Kenjiro Higashi2, ○Kaori Fukuzawa1,3, Etsuo Yonemochi1 (1. Grad. Sch. Pharm. Sci., Hoshi Univ., 2. Grad. Sch. Pharm. Sci., Chiba Univ., 3. Grad. Sch. Pharm. Sci., Osaka Univ.)
○Ziwei Ma1, Hiroshi Kamizawa1, Rento Ota1, Teruki Nii2, Takeshi Mori2,3, Yoshiki Katayama2,3,4,5, Akihiro Kishimura2,3,4,6 (1. Grad. Sch. Sys. Life Sci., Kyushu Univ., 2. Dept. of Applied Chem., Fac. of Eng., Kyushu Univ., 3. Ctr. for Future Chem., Kyushu Univ., 4. Ctr. for Molecular Systems, Kyushu Univ., 5. Ctr. for Adv. Med. Innov., Kyushu Univ., 6. RIKEN Ctr. for Emergent Matter Sci.)
[28ISP-31 (27P2-am1-071S)] Intracellular delivery of mRNA drugs using chemically modified dendrimers
○Moeka Hata1, Shota Oyama2, Tsuyoshi Yamamoto2, Hiroaki Kitagishi3, Shigeru Kawakami2, Hidetoshi Arima4, Asako Yamayoshi2 (1. Sch. Pharm. Sci., Nagasaki Univ., 2. Grad. Sch. Biomed. Sci., Nagasaki Univ., 3. Fac. Sci. Eng., Doshisha Univ., 4. Sch. Pharm., Daiichi Univ.)
○Naoko Konami1, Karen Ujiie1, Kasumi Sasaki1, Koji Okuwaki1, Hiroki Tanaka2, Hidetaka Akita3, Takayuki Furuishi1, Kaori Fukuzawa1,4, Etsuo Yonemochi1 (1. Sch. Pharm., Hoshi Univ., 2. Grad. Sch. Pharm. Sci., Chiba Univ., 3. Grad. Sch. Pharm. Sci., Tohoku Univ., 4. Grad. Sch. Pharm. Sci., Osaka Univ.)
○Nozomi Matsudaira1,2, Yuto Honda1,2, Syuhei Nagao1,2, Hiroaki Kinoh3, Takahiro Nomoto1,2, Xueying Liu 3, Anjaneyulu Dirisala 3, Yutaka Miura1,2, Kazunori Kataoka3, Nobuhiro Nishiyama1,2 (1. Department of Life Science and Technology, School of Life Science and Technology, Tokyo Institute of Technology, 2. Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, 3. Innovation Center of Nanomedicine (iCONM), Kawasaki Institute of Industrial Promotion)
○Shintaro Tamashiro1, Takaaki Ito1, Eriko Yamazoe1, Kohei Tahara1 (1. Gifu Pharmaceutical University)
○Kohei Yamada1, Atsushi Kambayashi1,2, Hideyuki Sato1, Satomi Onoue1 (1. Lab. of Biopharmacy, Sch. of Pharm. Sci., Univ. of Shizuoka, 2. Pharmaceutical Research and Technology Labs, Astellas Pharma. Inc.)
○Shiro Komba1, Rika Iwaura1, Takahito Kajiki2 (1. National Agriculture and Food Research Organization, 2. SUNUS CO., LTD )
○Yuno Suzuki1, Lisa Munakata1, Daiki Omata1, Keiichi Koizumi2, Ryo Suzuki1,3 (1. Fac. Pharma-Sci., Teikyo Univ., 2. Inst. Nat. Med., Univ. Toyama, 3. ACRO, Teikyo Univ.)
○yukari shigemoto-mogami1, kimiko nakayama-kitamura1, Tomomi Furihata2, hitoshi naraoka3,4, Michiya Matsusaki5, ddaiju yamazaki1, seiichi ishida1,6, kaoru sato1 (1. NIHS Divi. Pharmacol., 2. Tokyo Univ. Pharm. Life Sci.,, 3. Astellas Pharma Inc. , 4. SCA, 5. Grad. Sch. Eng. Sci., Osaka Univ. , 6. Grad. Sch. Eng. Sci., Sojo Univ. )